絞り込み

17083

広告

立教大学、就活中の学生がオンライン面接の課題などを調査 (大学ジャーナル/a>)

2020年5月31日、立教大学経営学部の中原淳研究室は、企業の採用活動におけるオンライン面接の課題や可能性に関する調査報告書を発表した。 「オンライン面接の実態...

  1. [企業] 年内のCOVID-19ワクチン...
  2. 5月の世界・平均気温が過去最高に 世界気...
  3. 動物実験、AI活用で9割減 (デイリース...
  4. 名門ウィーン・フィル 3か月ぶり公演再開...

ニュース一覧

Fusion of Large-Scale Genomic Knowledge and Frequency Data Computationally Prioritizes Variants in Epilepsy.

著者 Campbell IM , Rao M , Arredondo SD , Lalani SR , Xia Z , Kang SH , Bi W , Breman AM , Smith JL , Bacino CA , Beaudet AL , Patel A , Cheung SW , Lupski JR , Stankiewicz P , Ramocki MB , Shaw CA
PLoS Genet.2013 Sep ; 9(9):e1003797.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.

スターを付ける スターを付ける     (7view , 0users)

Full Text Sources

Medical

Curation and interpretation of copy number variants identified by genome-wide testing is challenged by the large number of events harbored in each personal genome. Conventional determination of phenotypic relevance relies on patterns of higher frequency in affected individuals versus controls; however, an increasing amount of ascertained variation is rare or private to clans. Consequently, frequency data have less utility to resolve pathogenic from benign. One solution is disease-specific algorithms that leverage gene knowledge together with variant frequency to aid prioritization. We used large-scale resources including Gene Ontology, protein-protein interactions and other annotation systems together with a broad set of 83 genes with known associations to epilepsy to construct a pathogenicity score for the phenotype. We evaluated the score for all annotated human genes and applied Bayesian methods to combine the derived pathogenicity score with frequency information from our diagnostic laboratory. Analysis determined Bayes factors and posterior distributions for each gene. We applied our method to subjects with abnormal chromosomal microarray results and confirmed epilepsy diagnoses gathered by electronic medical record review. Genes deleted in our subjects with epilepsy had significantly higher pathogenicity scores and Bayes factors compared to subjects referred for non-neurologic indications. We also applied our scores to identify a recently validated epilepsy gene in a complex genomic region and to reveal candidate genes for epilepsy. We propose a potential use in clinical decision support for our results in the context of genome-wide screening. Our approach demonstrates the utility of integrative data in medical genomics.
PMID: 24086149 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード